10.02.2021 13:16:56
|
Teva Pharma Projects FY21 Earnings In Line With Estimates - Quick Facts
(RTTNews) - While reporting its financial results for the fourth quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) forecast fiscal 2021 revenues in a range of $16.4 billion to $16.8 billion, and adjusted earnings per share in a range of $2.50 to $2.70. This compares to revenues of $16.7 billion and adjusted earnings per share of $2.57 per share for fiscal 2020.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.63 per share for the year on revenues of $16.76 billion. Analysts' estimates typically exclude special items.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Nachrichten
Analysen zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 14,85 | -0,34% |
|